High-flow nasal cannula therapy, factors affecting effective inspired oxygen fraction: an experimental adult bench model

被引:8
作者
Duprez, Frederic [1 ,5 ]
de Terwangne, C. [2 ]
Bellemans, V. [1 ]
Poncin, W. [3 ]
Reychler, G. [3 ]
Sorgente, A. [4 ]
Cuvelier, G. [5 ]
Mashayekhi, S. [1 ]
Wittebole, X. [6 ]
机构
[1] Ctr Hosp Epicura, Dept Intens Care, Hornu, Belgium
[2] Clin Univ St Luc, Dept Geriatr Med, Brussels, Belgium
[3] Catholic Univ Louvain, Dept Internal Med, Brussels, Belgium
[4] Ctr Hosp Epicura, Dept Cardiol, Hornu, Belgium
[5] Condorcet Sch, Lab Resp Physiol, Tournai, Belgium
[6] UCLouvain, Clin Univ St Luc, Dept Intens Care, Brussels, Belgium
关键词
Oxygenation through High Flow Delivery Systems; HFO; HFNC; Inspiratory flow; Minute ventilation; Effective inspired oxygen fraction; Double trunk mask; PRESSURE;
D O I
10.1007/s10877-021-00784-z
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Oxygenation through High Flow Delivery Systems (HFO) is described as capable of delivering accurate F-i(O2). Meanwhile, peak inspiratory flow <(V) over dot>(I)) of patients with acute hypoxemic respiratory failure can reach up to 120 L/min, largely exceeding HFO flow. Currently, very few data on the reliability of HFO devices at these high <(V) over dot>(I) are available. We sought to evaluate factors affecting oxygenation while using HFO systems at high <(V) over dot>(I) in a bench study. Spontaneous breathing was generated with a mechanical test lung connected to a mechanical ventilator Servo-i (R), set to volume control mode. Gas flow from a HFO device was delivered to the test lung. The influence on effective inspired oxygen fraction of three parameters (F-i(O2) 0.6, 0.8, and 1, <(V) over dot>(I) from 28 to 98.1 L/min, and HFO Gas Flows from 40 to 60 L/min) were analyzed and are reported. The present bench study demonstrates that during HFO treatment, measured F-i(O2) in the lung does not equal set F-i(O2) on the device. The substance of this variation (Delta F-i(O2)) is tightly correlated to <(V) over dot>(I) (Pearson's coefficient of 0.94, p-value< 0.001). Additionally, set F-i(O2) and Flow at HFO device appear to significatively affect Delta F-i(O2) as well (p-values < 0.001, adjusted to <(V) over dot>(I)). The result of multivariate linear regression indicates predictors (<(V) over dot>(I), Flow and set F-i(O2)) to explain 92% of the variance of delta F-i(O2) through K-Fold Cross Validation. Moreover, adjunction of a dead space in the breathing circuit significantly decreased Delta F-i(O2) (p <0.01). The present bench study did expose a weakness of HFO devices in reliability of delivering accurate F-I(O2) at high <(V) over dot>(I) as well as, to a lesser extent, at <(V) over dot>(I) below equivalent set HFO Flows. Moreover, set HFO flow and set F-I(O2) did influence the variability of effective inspired oxygen fraction. The adjunction of a dead space in the experimental set-up significantly amended this variability and should thus be further studied in order to improve success rate of HFO therapy.
引用
收藏
页码:1441 / 1448
页数:8
相关论文
共 50 条
  • [21] High-flow nasal cannula oxygen therapy in the management of acute respiratory distress syndrome secondary to opioid overdose
    Gulen, Muge
    Satar, Salim
    Yesiloglu, Onder
    Avci, Akkan
    Acehan, Selen
    [J]. TURKISH JOURNAL OF EMERGENCY MEDICINE, 2021, 21 (01): : 30 - 33
  • [22] High-Flow Nasal Cannula: A Promising Oxygen Therapy for Patients with Severe Bronchial Asthma Complicated with Respiratory Failure
    Geng, Wanru
    Batu, Wuliji
    You, Shuhong
    Tong, Zhaohui
    He, Hangyong
    [J]. CANADIAN RESPIRATORY JOURNAL, 2020, 2020
  • [23] Effect of humidified high-flow nasal cannula oxygen therapy on respiratory function recovery in stable COPD patients
    Lyu, Ruibing
    Wang, Wen
    Wang, Wenju
    Liu, Nian
    Xiao, Jinwen
    Lil, Xin
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (06): : 4074 - 4081
  • [24] Aerosol Delivery Efficiency With High-Flow Nasal Cannula Therapy in Neonatal, Pediatric, and Adult Nasal Upper-Airway and Lung Models
    DiBlasi, Robert M.
    Engberg, Rebecca J.
    Poli, Jonathan
    Carlin, Kristen E.
    Kontoudios, Niko
    Longest, Worth
    Kajimoto, Masaki
    [J]. RESPIRATORY CARE, 2024, 69 (09) : 1146 - 1160
  • [25] The Effects of Home High-Flow Nasal Cannula Oxygen Therapy on Clinical Outcomes in Patients with Severe COPD and Frequent Exacerbations
    Theunisse, Christiaan
    de Graaf, Netty T. C.
    Braam, Annemiek W. E.
    Vonk, Greet C.
    Baart, Sara J.
    Ponssen, Huibert H.
    Cheung, David
    [J]. JOURNAL OF CLINICAL MEDICINE, 2025, 14 (03)
  • [26] Oxygen therapy with high-flow nasal cannulas in children with acute bronchiolitis
    Zielinska, Anna
    Jassem-Bobowicz, Joanna
    Kwiatkowska, Joanna
    [J]. ANAESTHESIOLOGY INTENSIVE THERAPY, 2019, 51 (01) : 51 - 55
  • [27] High-Flow Nasal Cannula and Aerosolized β Agonists for Rescue Therapy in Children With Bronchiolitis: A Case Series
    Morgan, Sherwin E.
    Mosakowski, Steve
    Solano, Patti
    Hall, Jesse B.
    Tung, Avery
    [J]. RESPIRATORY CARE, 2015, 60 (09) : E161 - E165
  • [28] High-Flow Nasal Cannula Therapy as an Adjuvant Therapy for Respiratory Support during Endoscopic Techniques: A Narrative Review
    Corral-Blanco, Marta
    Sayas-Catalan, Javier
    Hernandez-Voth, Ana
    Rey-Terron, Laura
    Villena-Garrido, Victoria
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [29] Effectiveness of high-flow nasal cannula versus noninvasive ventilation and conventional oxygen therapy in patients weaned from invasive mechanical ventilation
    Amira Ahmed Ahmed Mahmoud Elghonemy
    Emad Korraa
    Rehab M. Mohammed
    [J]. The Egyptian Journal of Bronchology, 18 (1)
  • [30] High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial
    Hui, David
    Mahler, Donald A.
    Larsson, Liliana
    Wu, Jimin
    Thomas, Saji
    Harrison, Carol A.
    Hess, Kenneth
    Lopez-Mattei, Juan
    Thompson, Kara
    Gomez, Daniel
    Jeter, Melenda
    Lin, Steven
    Basen-Engquist, Karen
    Bruera, Eduardo
    [J]. ONCOLOGIST, 2021, 26 (08) : E1470 - E1479